Fibroblast Growth Factor and Insulin-Like Growth Factor Rescue Growth Cones of Sensory Neurites from Collapse After Tetracaine-Induced Injury

BACKGROUND: Basic fibroblast growth factor (bFGF) and insulin-like growth factor (IGF)-1 have multiple effects on cells, including proliferation, differentiation, and survival. In this study, we investigated the effects of different concentrations of IGF and bFGF on the morphology of growth cones of the developing sensory neurons after tetracaine-induced injury in vitro. METHODS: Dorsal root ganglia were isolated from chick embryos on embryonic day 7 or 8 and cultured for 24 hours. Tissues were then exposed to 100 &mgr;mol/L tetracaine for 60 minutes. The media were replaced by tetracaine-free media containing different concentrations of IGF, bFGF, or combination of IGF 50 ng/mL and bFGF 5 ng/mL and incubated for a further 24 hours. Growth cone collapse assays were then performed to assess regeneration of neurons. RESULTS: Exposure of dorsal root ganglia explants to tetracaine 100 &mgr;mol/L for 1 hour caused significant growth cone collapse 24 hours after washing out tetracaine (P < 0.01). It was found that adding bFGF (5, 10, 20, and 50 ng/mL) or IGF (50 and 100 ng/mL) to the replacement media significantly decreased growth cone collapse percentage at 24 hours after washout (P < 0.01); however, the low concentrations of bFGF (2 ng/mL) or IGF (25 ng/mL) did not cause significant change. Growth cone collapse after simultaneous addition of 5 ng/mL bFGF and 50 ng/mL IGF was statistically lower than the values after adding 5 ng/mL bFGF (P < 0.01), and it was marginally lower than 50 ng/mL IGF. CONCLUSION: bFGF and bIGF decreased growth cone collapse after tetracaine-induced injury in vitro.

[1]  S. Skaper,et al.  Selective survival of neurons from chick embryo sensory ganglionic dissociates utilizing serum-free supplemented medium. , 1980, Experimental cell research.

[2]  D. Kletsas,et al.  PDGF, bFGF and IGF-I stimulate the proliferation of intervertebral disc cells in vitro via the activation of the ERK and Akt signaling pathways , 2007, European Spine Journal.

[3]  S. Saito,et al.  Growth cone collapsing effect of lidocaine on DRG neurons is partially reversed by several neurotrophic factors. , 2002, Anesthesiology.

[4]  M. Garry,et al.  Functional Regeneration of Chronically Injured Sensory Afferents into Adult Spinal Cord after Neurotrophin Gene Therapy , 2001, The Journal of Neuroscience.

[5]  T. Lue,et al.  Insulin-like growth factor-I promotes proliferation and migration of cavernous smooth muscle cells. , 2001, Biochemical and biophysical research communications.

[6]  W. Zawada,et al.  IGF-1 and bFGF reduce glutaric acid and 3-hydroxyglutaric acid toxicity in striatal cultures , 2001, Journal of Inherited Metabolic Disease.

[7]  Z. Laron,et al.  Laron syndrome (primary growth hormone resistance or insensitivity): the personal experience 1958-2003. , 2004, The Journal of clinical endocrinology and metabolism.

[8]  D. Ishii,et al.  Insulin‐like growth factors protect against diabetic neuropathy: Effects on sensory nerve regeneration in rats , 1995, Journal of neuroscience research.

[9]  D. Newgreen,et al.  Fibroblast growth factor‐2 over‐rides insulin‐like growth factor‐I induced proliferation and cell survival in human neuroblastoma cells , 2004, Journal of cellular physiology.

[10]  M. Bahar,et al.  Neurological toxicity of the subarachnoid infusion of bupivacaine, lignocaine or 2-chloroprocaine in the rat. , 1986, British journal of anaesthesia.

[11]  S. Weiss,et al.  Insulin-Like Growth Factor-I Is Necessary for Neural Stem Cell Proliferation and Demonstrates Distinct Actions of Epidermal Growth Factor and Fibroblast Growth Factor-2 , 2001, The Journal of Neuroscience.

[12]  R. Schwartz,et al.  Targeted Expression of IGF‐1 Transgene to Skeletal Muscle Accelerates Muscle and Motor Neuron Regeneration , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[13]  M. Georgieff,et al.  Effects of basic fibroblast growth factor on hippocampal neurons after axonal injury. , 1997, The Journal of trauma.

[14]  A. Vercoutter-Edouart,et al.  FGF signals for cell proliferation and migration through different pathways. , 2000, Cytokine & growth factor reviews.

[15]  G. Glazner,et al.  Elevated insulin-like growth factor (IGF) gene expression in sciatic nerves during IGF-supported nerve regeneration. , 1994, Brain research. Molecular brain research.

[16]  M. Igarashi,et al.  Effects of Inhalational Anesthetics on Biochemical Events in Growing Neuronal Tips , 1993, Anesthesiology.

[17]  A. Moses,et al.  Recombinant Human Insulin-Like Growth Factor I Increases Insulin Sensitivity and Improves Glycemic Control in Type II Diabetes , 1996, Diabetes.

[18]  D. S. Cowen,et al.  Interaction of FGF-2 with IGF-1 and BDNF in stimulating Akt, ERK, and neuronal survival in hippocampal cultures , 2007, Brain Research.

[19]  J. Fiddes,et al.  Basic fibroblast growth factor in human rhabdomyosarcoma cells: implications for the proliferation and neovascularization of myoblast-derived tumors. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[20]  W. Young,et al.  Insulin Growth Factor-1 Gene Transfer Enhances Neurovascular Remodeling and Improves Long-Term Stroke Outcome in Mice , 2008, Stroke.

[21]  K. Mikoshiba,et al.  Basic fibroblast growth factor rescues CNS neurons from cell death caused by high oxygen atmosphere in culture , 1992, Brain Research.

[22]  R. Farrar,et al.  Muscle-specific inactivation of the IGF-I receptor induces compensatory hyperplasia in skeletal muscle. , 2002, The Journal of clinical investigation.

[23]  H. Azuma,et al.  Impact of serum insulin-like growth factor-1 on early prognosis in acute myocardial infarction. , 2008, Internal medicine.

[24]  D. Pleasure,et al.  Basic fibroblast growth factor prevents cAMP‐induced apoptosis in cultured Schwann cells , 1997, Journal of neuroscience research.

[25]  P. Caroni,et al.  Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors , 1990, The Journal of cell biology.

[26]  H. Obata,et al.  Direct Neurotoxicity of Tetracaine on Growth Cones and Neurites of Growing Neurons In Vitro , 2001, Anesthesiology.

[27]  M. García-Fernández,et al.  Low doses of insulin-like growth factor I improve insulin resistance, lipid metabolism, and oxidative damage in aging rats. , 2008, Endocrinology.

[28]  J. Pavelić,et al.  Biological & physiological aspects of action of insulin-like growth factor peptide family. , 2007, The Indian journal of medical research.

[29]  J. Neal,et al.  The neurotoxicity of drugs given intrathecally (spinal) , 1999, Anesthesia and analgesia.

[30]  Y. Tabata,et al.  A novel bFGF-GH injection therapy for two patients with severe ischemic limb pain , 2008, Journal of Anesthesia.